Back to search
de Novo or Restenosis Lesions
Clinical trial pipeline · Data from ClinicalTrials.gov
See which de Novo or Restenosis Lesions trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which de Novo or Restenosis Lesions trials you may qualify forThis clinical trial adopts a retrospective, multicenter design with data registered and collected via an Electronic Data Capture (EDC) system. A total of 252 el…
MedJ-01 Ridaforolimus Eluting Coronary Stent System is a single use device/drug combination product comprising: * A mounted Cobalt Chromium (CoCr) alloy based…
In this study, the investigators preformed OCT before and after DCB treatment, as well as at 6 months of follow-up, to assess the tissue characterization. The a…
Objectives: PRIMARY OBJECTIVE: To compare the in-stent late loss at 9 months of paclitaxel- and sirolimus- eluting stents with the late loss of bare metal con…
To assess the safety and effectiveness of intravascular brachytherapy for the treatment of intrastent restenosis of coronary lesions with the Galileo system